Active, not recruitingPhase 2NCT05418049

Evaluating the Neurophysiologic and Clinical Effects of Single Dose Drug Challenge

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Children's Hospital Medical Center, Cincinnati
Principal Investigator
Craig A. Erickson, M.D.
Children's Hospital Medical Center, Cincinnati
Intervention
Baclofen(drug)
Enrollment
45 enrolled
Eligibility
18-45 years · All sexes
Timeline
20222026

Study locations (1)

Collaborators

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05418049 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials